Geode Capital Management, LLC Capricor Therapeutics, Inc. Transaction History

Geode Capital Management, LLC

$1.12 Trillion
Q2 2024

A detailed history of Geode Capital Management, LLC transactions in Capricor Therapeutics, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 641,573 shares of CAPR stock, worth $14.1 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

641,573

Previous 328,477 95.32%

Holding current value

$14.1 Million

Previous $2.23 Million 37.22%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	BUY	$4.63 - $7.09 $1.45 Million - $2.22 Million	313,096 Added 95.32%	641,573 $3.06 Million
Q1 2024 May 13, 2024	BUY	$3.61 - $6.88 $44,327 - $84,479	12,279 Added 3.88%	328,477 $2.23 Million
Q4 2023 Feb 13, 2024	BUY	$2.71 - $5.08 $128,914 - $241,655	47,570 Added 17.71%	316,198 $1.55 Million
Q3 2023 Nov 13, 2023	SELL	$3.42 - $7.85 $101,553 - $233,097	-29,694 Reduced 9.95%	268,628 $918,000
Q2 2023 Aug 11, 2023	BUY	$3.76 - $5.05 $250,540 - $336,496	66,633 Added 28.76%	298,322 $1.43 Million
Q1 2023 May 15, 2023	BUY	$3.78 - $5.03 $21,088 - $28,062	5,579 Added 2.47%	231,689 $977,000
Q4 2022 Feb 13, 2023	BUY	$3.36 - $6.55 $13,698 - $26,704	4,077 Added 1.84%	226,110 $872,000
Q3 2022 Nov 14, 2022	BUY	$3.61 - $6.08 $57,651 - $97,097	15,970 Added 7.75%	222,033 $1.33 Million
Q2 2022 Aug 12, 2022	SELL	$2.89 - $4.51 $44,936 - $70,125	-15,549 Reduced 7.02%	206,063 $719,000
Q1 2022 May 13, 2022	BUY	$2.83 - $5.68 $45,393 - $91,107	16,040 Added 7.8%	221,612 $760,000
Q3 2021 Nov 12, 2021	BUY	$3.8 - $5.23 $78,211 - $107,643	20,582 Added 11.13%	205,572 $826,000
Q2 2021 Aug 13, 2021	BUY	$3.16 - $5.72 $42,897 - $77,649	13,575 Added 7.92%	184,990 $948,000
Q1 2021 May 12, 2021	BUY	$3.63 - $7.93 $179,935 - $393,082	49,569 Added 40.68%	171,415 $802,000
Q4 2020 Feb 12, 2021	BUY	$3.43 - $5.23 $21,718 - $33,116	6,332 Added 5.48%	121,846 $417,000
Q3 2020 Nov 13, 2020	BUY	$4.08 - $9.81 $343,246 - $825,305	84,129 Added 268.05%	115,514 $606,000
Q2 2020 Aug 13, 2020	BUY	$1.0 - $8.5 $18,340 - $155,890	18,340 Added 140.59%	31,385 $144,000
Q2 2019 Aug 14, 2019	BUY	$2.75 - $6.4 $35,873 - $83,488	13,045 New	13,045 $43,000

Others Institutions Holding CAPR

# of Institutions

Shares Held

6.32M

Call Options Held

210K

Put Options Held

374K

View Full List

About CAPRICOR THERAPEUTICS, INC.

Ticker CAPR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 24,346,200
Market Cap $535M
Description
Capricor Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the development of transformative cell and exosome-based therapeutics for the treatment and prevention of spectrum of diseases and disorders. Its lead candidate, CAP-1002, an allogeneic cardiac-derived cell therapy, which has completed phase III clinical trial for th...

More about CAPR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Account

Geode Capital Management, LLC Capricor Therapeutics, Inc. Transaction History